Secondary Logo

Journal Logo

Erratum

Regarding Amsterdam JD and Kim TT article

J Clin Psychopharmacol 2019;39:344–350

Journal of Clinical Psychopharmacology: November/December 2019 - Volume 39 - Issue 6 - p 633
doi: 10.1097/JCP.0000000000001143
Erratum
Free

The Editors received the following correction from the authors, Dr. Jay D. Amsterdam and Thomas T. Kim, for their article published in the July–August 2019 issue of the Journal.

We would like to bring to your readers’ attention the presence of an error in our article in the Journal entitled “Prior antidepressant treatment trials may predict a greater risk of depressive relapse during antidepressant maintenance therapy” by Amsterdam JD and Kim TT (J Clin Psychopharmacol 2019; 39:344-350).

Specifically, we were informed by one of your nice journal readers that one of our Odds Ratios (OR) may have been incorrectly reported out, and that the reported OR value suggested a ‘reduction’, rather than an ‘increase’, in the likelihood of depressive relapse with each increase in the number of prior antidepressant treatment trials. We have examined this issue, and we agree with the reader.

The error occurred on page 47 of the article in the Results section, under the sub-heading: Effect of Prior Antidepressant Treatment Trials on the Odds of Depressive Relapse. It is located in the last paragraph, stated verbatim as:

"After controlling for age, sex, race, number of prior depressive episodes, number of prior hypomanic episodes, age of onset of first depression, age of onset of first hypomania, baseline HRSD, duration of current depressive episode, number of prior antidepressant trials, type of treatment condition, and rapid cycling status, only the number of prior antidepressant treatment trials was associated with an increased odds of relapse (OR = 0.38, z = 2.11, P = 0.04)."

The OR value of 0.38 is incorrect. The Correct OR value should read 1.47.

Thus, the correct sentence should read:

"After controlling for age, sex, race, number of prior depressive episodes, number of prior hypomanic episodes, age of onset of first depression, age of onset of first hypomania, baseline HRSD, duration of current depressive episode, number of prior antidepressant trials, type of treatment condition, and rapid cycling status, only the number of prior antidepressant treatment trials was associated with an increased odds of relapse (OR = 1.47, z = 2.11, P = 0.04)."

Please note that this change does not otherwise alter the overall conclusions drawn from our study results.

Thank you for providing this correction to your readers.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.